Kenvue’s stock, which had hit a record low in recent weeks, was headed for its best day ever, while Kimberly-Clark’s stock ...

The owner of Kleenex and Huggies will acquire the company that has fought unproven claims by the Trump administration that a ...

The agreement, which combines the maker of Huggies diapers with the owner of the painkiller brand, will create a global ...

Kleenex and Cottonelle maker Kimberly-Clark said it's buying Tylenol maker Kenvue in a $48.7 billion deal. Kenvue ( KVUE) ...

The firm noted that Kimberly-Clark is paying a “significant equity premium” to acquire Kenvue. The deal values Kenvue at ...

Leading the latest haul is Kimberly-Clark Corp., which has agreed to buy struggling Tylenol maker Kenvue Inc. for roughly $40 ...

Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer ...

(Reuters) -Kleenex maker Kimberly-Clark said on Monday it will buy Kenvue for more than $40 billion in a landmark deal for ...

Kimberly-Clark is buying Kenvue, the maker of Tylenol, after months of controversy around whether the medicine is linked to autism.

The announcement comes just weeks after President Trump publicly spread debunked claims that Tylenol consumption is linked to autism.